Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris E Brightling

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Immunology and Allergy Clinics of North America|August 14, 2022
Novel Therapeutic Strategies in Asthma-Chronic Obstructive Pulmonary Disease OverlapSarah Diver, Chris E Brightling, Neil J Greening
Current Opinion in Allergy and Clinical Immunology|January 16, 2007
The reclassification of asthma based on subphenotypesRuth H Green, Chris E Brightling, Peter Bradding
Respiratory Research|October 16, 2020
Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?Andrew Menzies-Gow, Michael E Wechsler, Chris E Brightling
Respirology (Carlton, Vic.)|February 4, 2015
Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary diseaseOsama Eltboli, Vijay Mistry, Bethan Barker, et al.
Respirology (Carlton, Vic.)|March 10, 2010
Mannitol and AMP do not induce bronchoconstriction in eosinophilic bronchitis: further evidence for dissociation between airway inflammation and bronchial hyperresponsivenessAmisha Singapuri, Sue McKenna, Chris E Brightling, et al.
International Journal of Molecular Sciences|November 26, 2022
Human Lung Mast Cells: Therapeutic Implications in AsthmaRemo Poto, Gjada Criscuolo, Gianni Marone, et al.
European Journal of Immunology|September 16, 2008
Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migrationS Mark Duffy, Glenn Cruse, Sarah L Cockerill, et al.
Thorax|September 1, 2010
Refractory asthma in the UK: cross-sectional findings from a UK multicentre registryLiam G Heaney, Chris E Brightling, Andrew Menzies-Gow, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 15, 2025
Diagnosis and treatment options for T2-low asthmaDennis Thomas, Yuto Hamada, Peter Gibson, et al.
Thorax|May 15, 2012
Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma RegistryJoan Sweeney, Chris E Brightling, Andrew Menzies-Gow, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Immunology and Allergy Clinics of North America|August 14, 2022
Novel Therapeutic Strategies in Asthma-Chronic Obstructive Pulmonary Disease OverlapSarah Diver, Chris E Brightling, Neil J Greening
Current Opinion in Allergy and Clinical Immunology|January 16, 2007
The reclassification of asthma based on subphenotypesRuth H Green, Chris E Brightling, Peter Bradding
Respiratory Research|October 16, 2020
Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?Andrew Menzies-Gow, Michael E Wechsler, Chris E Brightling
Respirology (Carlton, Vic.)|February 4, 2015
Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary diseaseOsama Eltboli, Vijay Mistry, Bethan Barker, et al.
Respirology (Carlton, Vic.)|March 10, 2010
Mannitol and AMP do not induce bronchoconstriction in eosinophilic bronchitis: further evidence for dissociation between airway inflammation and bronchial hyperresponsivenessAmisha Singapuri, Sue McKenna, Chris E Brightling, et al.
International Journal of Molecular Sciences|November 26, 2022
Human Lung Mast Cells: Therapeutic Implications in AsthmaRemo Poto, Gjada Criscuolo, Gianni Marone, et al.
European Journal of Immunology|September 16, 2008
Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migrationS Mark Duffy, Glenn Cruse, Sarah L Cockerill, et al.
Thorax|September 1, 2010
Refractory asthma in the UK: cross-sectional findings from a UK multicentre registryLiam G Heaney, Chris E Brightling, Andrew Menzies-Gow, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 15, 2025
Diagnosis and treatment options for T2-low asthmaDennis Thomas, Yuto Hamada, Peter Gibson, et al.
Thorax|May 15, 2012
Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma RegistryJoan Sweeney, Chris E Brightling, Andrew Menzies-Gow, et al.
Pageof 5